All due respect hylander, but with the history this company/CEO has, especially recently, I think only results will matter now, and not anything else (PR, conf call, interviews). In fact, I think publicity efforts hurts more than helps, as those efforts now all are seen as nothing more than "pump" activities. There are four events that will help: (1) actual funding "in the bank," not in return for shares (dilution); (2) IPO of NuGen; (3) vaccine mass-production for deployment; or, (4) report of significant generation of revenue from any of the long list of touted other products/services by Generex over the last 3-4 years. Otherwise, I fear the little boy has cried "wolf" one too many times.
(4)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links